Soy protein may alleviate osteoarthritis symptoms

Phytomedicine

Volumn 11, Issue 7-8, 2004, Pages 567-575

  Arjmandi, B H ^a   Khalil, D A ^a   Lucas, E A ^a   Smith, B J ^a   Sinichi, N ^a   Hodges, S B ^a   Juma, S ^a   Munson, M E ^a   Payton, M E ^a   Tivis, R D ^b   Svanborg, A ^c  

^a OKLAHOMA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Glycoprotein 39 (YKL 40); Insulin like growth factor I (IGF I); Osteoarthritis; Soy protein

Indexed keywords

BIOLOGICAL MARKER; GLYCOPROTEIN GP 39; PLACEBO; SOMATOMEDIN C; SOYBEAN PROTEIN;

ADULT; AGED; ALTERNATIVE MEDICINE; ARTICLE; CARTILAGE DEGENERATION; CHRONIC PAIN; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HERB; HUMAN; KNEE FUNCTION; KNEE OSTEOARTHRITIS; KNEE PAIN; MAJOR CLINICAL STUDY; MALE; METABOLISM; NUTRITION; PAIN ASSESSMENT; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SELF REPORT; SYMPTOMATOLOGY; SYNTHESIS; TREATMENT OUTCOME;

EID: 19944404413     PISSN: 09447113     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phymed.2003.11.001     Document Type: Article

References (33)

1. Abrams, S.E., 1990. The Pain Clinic Manual. JB Lippincott Company, Philadelphia, PA.
2. Akiyama, T., Ishida, J., Nakagawa, S., Ogawara, H., Watanabe, S.-I., Itoh, N., Shibuya, M., Fukami, Y., 1987. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J. Biol. Chem. 262, 5592-5595.
3. American Academy of Orthopaedic Surgeons, 1965. Joint motion-method and recording. American Academy of Orthopaedic Surgeons, Chicago, IL.
4. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines, 2000. Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. Arthritis Rheum., 43, 1905-1915.
5. Anderson, J.W., Johnstone, B.M., Cook-Newell, M.E., 1995. Meta-analysis of the effects of soy protein intake on serum lipids. N. Engl. J. Med. 333, 276-282.
6. Arjmandi, B.H., Smith, B.J., 2002. Soy isoflavones' osteoprotective role in postmenopausal women: mechanism of action. J. Nutr. Biochem. 13, 130-137.
7. Bassleer, C.T., Franchimont, P.P., Henrotin, Y.E., Franchimont, N.M., Geenen, V.G., Reginster, J.Y., 1996. Effects of ipriflavone and its metabolites on human articular chondrocytes cultivated in clusters. Osteoarthr. Cartilage 4, 1-8.
8. Blotman, F., Maheu, E., Wulwik, A., Caspard, H., Lopez, A., 1997. Efficacy and safety of avocado/soybean unsaponifiables in the treatment of symptomatic osteoarthritis of the knee and hip. A prospective, multicenter, three-month, randomized, double-blind, placebo-controlled trial. Rev. Rheum. Engl. Ed. 64, 825-834.
9. Clancy, R.M., Amin, A.R., Abramson, S.B., 1998. The role of nitric oxide in inflammation and immunity. Arthritis Rheum. 41, 1141-1151.
10. Dawson-Basoa, M.E., Gintzler, A.R., 1996. Estrogen and progesterone activate spinal kappa-opiate receptor analgesic mechanisms. Pain 64, 608-615.
11. Geng, Y., Maier, R., Lotz, M., 1995. Tyrosine kinases are involved with the expression of inducible nitric oxide synthase in human articular chondrocytes. J. Cell Physiol. 163, 545-554.
12. Guccione, A.A., Felson, D.T., Anderson, J.J., Anthony, J.M., Zhang, Y., Wilson, P.W., Kelly-Hayes, M., Wolf, P.A., Kreger, B.E., Kannel, W.B., 1994. The effects of specific medical conditions on the functional limitations of elders in the Framingham Study. Am. J. Public Health 84, 351-358.
13. Henrotin, Y.E., Labasse, A.H., Jaspar, J.M., De Groote, D.D., Zheng, S.X., Guillou, G.B., Reginster, J.Y., 1998. Effects of three avocado/soybean unsaponifiable mixtures on metalloproteinases, cytokines and prostaglandin E2 production by human articular chondrocytes. Clin. Rheumatol. 17, 31-39.
14. Kosinski, M., Keller, S.D., Ware Jr., J.E., Hatoum, H.T., Kong, S.X., 1999. The SF-36 Health Survey as a generic outcome measure in clinical trials of patients with osteoarthritis and rheumatoid arthritis: relative validity of scales in relation to clinical measures of arthritis severity. Med. Care 37, MS23-MS39.
15. Kuiper, G.G., Lemmen, J.G., Carlsson, B., Corton, J.C., Safe, S.H., van der Saag, P.T., van der, B.B., Gustafsson, J.A., 1998. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 139, 4252-4263.
16. Laughton, M.J., Evans, P.J., Moroney, M.A., Hoult, J.R.S., Halliwell, B., 1991. Inhibition of mammalian 5-lipoxygenase and cyclooxygenase by flavonoids and phenolic dietary additives. Biochem. Pharmacol. 42, 1673-1681.
17. LeGrand, A., Fermor, B., Fink, C, Pisetsky, D.S., Weinberg, J.B., Vail, T.P., Guilak, F., 2001. Interleukin-1, tumor necrosis factor alpha, and interleukin-17 synergistically up-regulate nitric oxide and prostaglandin E2 production in explants of human osteoarthritic knee menisci. Arthritis Rheum. 44, 2078-2083.
18. Maheu, E., Mazieres, B., Valat, J.P., Loyau, G., Le, L.X., Bourgeois, P., Grouin, J.M., Rozenberg, S., 1998. Symptomatic efficacy of avocado/soybean unsaponifiables in the treatment of osteoarthritis of the knee and hip: a prospective, randomized, double-blind, placebo-controlled, multicenter clinical trial with a six-month treatment period and a two-month followup demonstrating a persistent effect. Arthritis Rheum. 41, 81-91.
19. Manthey, J.A., 2000. Biological properties of flavonoids pertaining to inflammation. Microcirculation 7, S29-34.
20. Maroney, M.A., Alcaraz, M.J., Forder, R.A., Carey, F., Hoult, R.S., 1988. Selectivity of neutrophil 5-lipooxygenase and cyclooxygenase inhibition by an anti-inflammatory glycoside and related aglycone flavonoids. J. Pharm. Pharmacol. 40, 787-792.
21. Martel-Pelletier, J., Di Battista, J.A., Lajeunesse, D., Pelletier, J.P., 1998. IGF/IGFBP axis in cartilage and bone in osteoarthritis pathogenesis. Inflamm. Res. 47, 90-100.
22. McAlindon, T.E., LaValley, M.P., Gulin, J.P., Felson, D.T., 2000. Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis. JAMA 283, 1469-1475.
23. Melzack, R., 1975. The McGill Pain Questionnaire: major properties and scoring methods. Pain 1, 277-299.
24. Messina, M.J., Persky, V., Setchell, K.D., Barnes, S., 1994. Soy intake and cancer risk: a review of the in vitro and in vivo data. Nutr. Cancer 21, 113-131.
25. Ng, M.C., Harper, R.P., Le, C.T., Wong, B.S., 1999. Effect of estrogen on the condylar cartilage of the rat. J. Oral. Maxillofac. Surg. 57, 818-823.
26. Setchell, K.D., 2001. Soy isoflavones-benefits and risks from nature's selective estrogen receptor modulators (SERMs). J. Am. Coll. Nutr. 20, 354S-362S.
27. Shir, Y., Campbell, J.N., Raja, S.N., Seltzer, Z., 2002. The correlation between dietary soy phytoestrogens and neuropathic pain behavior in rats after partial denervation. Anesth. Analg. 94, 421-426.
28. Tesch, G.H., Handley, C.J., Cornell, H.J., Herington, A.C., 1992. Effects of free and bound insulin-like growth factors on proteoglycan metabolism in articular cartilage explants. J. Orthop. Res. 10, 14-22.
29. Tsai, C.L., Liu, T.K., 1992a. Inhibition of estradiol-induced early osteoarthritic changes by tamoxifen. Life Sci. 50, 1943-1951.
30. Tsai, C.L., Liu, T.K., 1992b. Upregulation of estrogen receptors in rabbit osteoarthritic cartilage. Life Sci. 50, 1727-1735.
31. Tsai, C.L., Liu, T.K., Chen, T.J., 1992. Estrogen and osteoarthritis: a study of synovial estradiol and estradiol receptor binding in human osteoarthritic knees. Biochem. Biophys. Commun. 183, 1287-1291.
32. Ushiyama, T., Ueyama, H., Inoue, K., Ohkubo, I., Hukuda, S., 1999. Expression of genes for estrogen receptors alpha and beta in human articular chondrocytes. Osteoarthr. Cartilage 7, 560-566.
33. Volck, B., Johansen, J.S., Stoltenberg, M., Garbarsch, C., Price, P.A., Ostergaard, M., Ostergaard, K., Lovgreen-Nielsen, P., Sonne-Holm, S., Lorenzen, I., 2001. Studies on YKL-40 in knee joints of patients with rheumatoid arthritis and osteoarthritis. Involvement of YKL-40 in the joint pathology. Osteoarthr. Cartilage 9, 203-214.